ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      96,641.45
      -0.58%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atea Pharmaceuticals Inc (AVIR)

      7. Atea Pharmaceuticals Inc (AVIR) Options

      AVIR Atea Pharmaceuticals Inc

      3.19
      0.06 (1.92%)
      Dec 21 2024 - Closed
      Delayed by 15 minutes

      AVIR Jan 17 2025 5 Call

      View Full AVIR Chain
      0.04 0.00 (0.00%)
      Bid 0.04 Volume 0 Exp. Date Jan 17 2025
      Ask 0.05 Open Interest 477 Day's Range 0.00 - 0.00
      Open 0.00 Prev Close 0.04 Last Trade - -

      AVIR Option Chain - Jan 17 2025

      AVIR Options Flow

      Calls

      StrikeBid PriceAsk PriceLast PriceChange %VolumeOPEN INT
      2.500.750.800.7626.67 %2081
      5.000.040.050.040.00 %0477

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Puts

      StrikeBid PriceAsk PriceLast PriceChange %VolumeOPEN INT
      2.500.050.050.050.00 %0719
      5.000.651.901.30-5.80 %1014

      AVIR Latest iHub Posts

      DewDiligence
      AVIR phase-3 COVID trial fails—stock rises:
      Fri Sep 13, 2024 12:27 PM
      Monksdream
      AVIR under $4
      Mon Sep 2, 2024 4:50 PM
      DewDiligence
      AVIR reports 2Q24 results—6/30/24 cash=$502.2M—down_from_$542M_at_3/31/24:
      Wed Aug 7, 2024 4:15 PM
      DewDiligence
      AVIR 1Q24 results:
      Tue May 14, 2024 4:25 PM
      Monksdream
      AVIR under $5
      Sun May 5, 2024 10:46 AM
      DewDiligence
      AVIR completes enrollment of phase-3 COVID trial—cancels interim analyses:
      Wed Mar 27, 2024 11:37 AM
      DewDiligence
      AVIR phase-3 COVID update:
      Wed Feb 28, 2024 7:50 PM
      DewDiligence
      AVIR rejects Tang buyout offer, as expected:
      Tue May 30, 2023 10:45 AM
      More AVIR Messages

      Your Recent History

      USOTC
      IGPK
      Intergrated Cannabis Sol... (PK)
      USOTC
      AABB
      Asia Broadband (PK)
      NASDAQ
      COOP
      Mr Cooper
      NYSE
      IONQ
      IonQ
      USOTC
      ELTP
      Elite Pharmaceuticals (QB)
      USOTC
      NBRI
      North Bay Resources (PK)
      USOTC
      DBMM
      Digital Brand Media and ... (PK)
      NASDAQ
      AVXL
      Anavex Life Sciences
      NASDAQ
      LWLG
      Lightwave Logic
      USOTC
      KBLB
      Kraig Biocraft Laborator... (QB)
      USOTC
      FNMA
      Fannie Mae (QB)
      USOTC
      NWBO
      Northwest Biotherapeutics (QB)
      USOTC
      HMBL
      HUMBL (PK)
      USOTC
      BIEL
      Bioelectronics (PK)
      USOTC
      CGAC
      Code Green Apparel (PK)
      NASDAQ
      TNXP
      Tonix Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads